Recruiting studies: Acute Schizophrenia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
Phase 3 · 1 location(s) · Otsuka Pharmaceutical Co., Ltd. · NCT05325645 Vaping and Smoking Project in People With Schizophrenia
NA · 1 location(s) · State University of New York at Buffalo · NCT06944847 Immune Mechanisms of Antipsychotic Treatment Response
Phase N/A · 1 location(s) · King's College London · NCT06687694 FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
NA · 8 location(s) · Stephanie Mehl · NCT07645443 Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Phase 3 · 13 location(s) · LB Pharmaceuticals Inc. · NCT07363577 Cerebellum-based Imaging Neural Markers for Antipsychotic Response
Phase 4 · 1 location(s) · Northwell Health · NCT07483294

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.